Review Article
Therapeutic Effects and Mechanisms of Action of Garlic (Allium sativum) on Nonalcoholic Fatty Liver Disease: A Comprehensive Systematic Literature Review
Table 2
Summary of the human studies on the effect of garlic on NAFLD.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Family 11 subfamily A member 1, CYP17A1: cytochrome P450 17A1, CYP21: cytochrome P450c21, CAT: catalase, COX: cyclooxygenase, assay, FBG: fasting blood glucose, FSH: follicle-stimulating hormone, GKG: glucokinase, GPX: glutathione peroxidase, HDL-C: high-density lipoprotein cholesterol, HMGCR: hydroxy-3-methylglutaryl-CoA, HOMA-IR: homeostasis model of assessment-insulin resistance, HSD3B1: hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1, ICP-OES: inductively coupled plasma optical emission spectrometry, IGF1: insulin like growth factor 1, IL: interleukin, IR: insulin resistance, LDL-C: low-density lipoprotein cholesterol, LH: luteinizing hormone, and MDA: malondialdehyde. |